Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators.

Cheng G, Zielonka J, Hardy M, Ouari O, Chitambar CR, Dwinell MB, Kalyanaraman B.

Oncotarget. 2019 May 28;10(37):3518-3532. doi: 10.18632/oncotarget.26943. eCollection 2019 May 28.

PMID:
31191823
2.

Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals.

Besson E, Gastaldi S, Bloch E, Zielonka J, Zielonka M, Kalyanaraman B, Aslan S, Karoui H, Rockenbauer A, Ouari O, Hardy M.

Analyst. 2019 Jun 10. doi: 10.1039/c9an00468h. [Epub ahead of print]

PMID:
31180410
3.

High-Throughput Screening of NOX Inhibitors.

Zielonka J, Zielonka M, Cheng G, Hardy M, Kalyanaraman B.

Methods Mol Biol. 2019;1982:429-446. doi: 10.1007/978-1-4939-9424-3_25.

PMID:
31172487
4.

HPLC-Based Monitoring of Oxidation of Hydroethidine for the Detection of NADPH Oxidase-Derived Superoxide Radical Anion.

Zielonka J, Zielonka M, Kalyanaraman B.

Methods Mol Biol. 2019;1982:243-258. doi: 10.1007/978-1-4939-9424-3_14.

PMID:
31172476
5.

Why illiberal politicians are winning.

Zielonka J.

Nat Hum Behav. 2019 May 31. doi: 10.1038/s41562-019-0635-1. [Epub ahead of print] No abstract available.

PMID:
31150014
6.

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.

Cheng G, Zhang Q, Pan J, Lee Y, Ouari O, Hardy M, Zielonka M, Myers CR, Zielonka J, Weh K, Chang AC, Chen G, Kresty L, Kalyanaraman B, You M.

Nat Commun. 2019 May 17;10(1):2205. doi: 10.1038/s41467-019-10042-1.

7.

Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity.

Pan J, Lee Y, Cheng G, Zielonka J, Zhang Q, Bajzikova M, Xiong D, Tsaih SW, Hardy M, Flister M, Olsen CM, Wang Y, Vang O, Neuzil J, Myers CR, Kalyanaraman B, You M.

iScience. 2018 May 25;3:192-207. doi: 10.1016/j.isci.2018.04.013. Epub 2018 Apr 22.

8.

Foreword to the Free Radical Biology and Medicine Special Issue on ¨Current fluorescence and chemiluminescence approaches in free radical and redox biology¨.

Radi R, Denicola A, Morgan B, Zielonka J.

Free Radic Biol Med. 2018 Nov 20;128:1-2. doi: 10.1016/j.freeradbiomed.2018.09.027. No abstract available.

PMID:
30293645
9.

Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies.

Kalyanaraman B, Cheng G, Zielonka J, Bennett B.

Cell Biochem Biophys. 2019 Mar;77(1):89-98. doi: 10.1007/s12013-018-0858-1. Epub 2018 Sep 26.

PMID:
30259334
10.

Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.

Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, Franke AM, Maeda D, Zielonka J, Münk C, Wei G, VandeWoude S, Löchelt M.

Retrovirology. 2018 May 16;15(1):38. doi: 10.1186/s12977-018-0419-0.

11.

Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future.

Cheng G, Zielonka M, Dranka B, Kumar SN, Myers CR, Bennett B, Garces AM, Dias Duarte Machado LG, Thiebaut D, Ouari O, Hardy M, Zielonka J, Kalyanaraman B.

J Biol Chem. 2018 Jun 29;293(26):10363-10380. doi: 10.1074/jbc.RA118.003044. Epub 2018 May 8.

PMID:
29739855
12.

Kindlin-3 negatively regulates the release of neutrophil extracellular traps.

Xu Z, Ni B, Cao Z, Zielonka J, Gao J, Chen F, Kalyanaraman B, White GC, Ma YQ.

J Leukoc Biol. 2018 Sep;104(3):597-602. doi: 10.1002/JLB.3AB0118-005R. Epub 2018 Apr 14.

PMID:
29656482
13.

Small-molecule luminescent probes for the detection of cellular oxidizing and nitrating species.

Zielonka J, Kalyanaraman B.

Free Radic Biol Med. 2018 Nov 20;128:3-22. doi: 10.1016/j.freeradbiomed.2018.03.032. Epub 2018 Mar 19. Review.

PMID:
29567392
14.

Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316-327].

Kalyanaraman B, Cheng G, Hardy M, Ouari O, Lopez M, Joseph J, Zielonka J, Dwinell MB.

Redox Biol. 2018 Jun;16:426-427. doi: 10.1016/j.redox.2018.03.001. Epub 2018 Mar 13. No abstract available.

15.

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies.

Kalyanaraman B, Cheng G, Hardy M, Ouari O, Bennett B, Zielonka J.

Redox Biol. 2018 May;15:347-362. doi: 10.1016/j.redox.2017.12.012. Epub 2017 Dec 26. Review.

16.

Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function.

Popp O, Moser S, Zielonka J, Rüger P, Hansen S, Plöttner O.

MAbs. 2018 Feb/Mar;10(2):290-303. doi: 10.1080/19420862.2017.1405203. Epub 2017 Dec 12.

17.

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2018 Apr;14:694-696. doi: 10.1016/j.redox.2017.10.001. Epub 2017 Oct 26. No abstract available.

18.

Detection and Characterization of Reactive Oxygen and Nitrogen Species in Biological Systems by Monitoring Species-Specific Products.

Hardy M, Zielonka J, Karoui H, Sikora A, Michalski R, Podsiadły R, Lopez M, Vasquez-Vivar J, Kalyanaraman B, Ouari O.

Antioxid Redox Signal. 2018 May 20;28(15):1416-1432. doi: 10.1089/ars.2017.7398. Epub 2017 Nov 17. Review.

19.

A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.

Kalyanaraman B, Cheng G, Hardy M, Ouari O, Lopez M, Joseph J, Zielonka J, Dwinell MB.

Redox Biol. 2018 Apr;14:316-327. doi: 10.1016/j.redox.2017.09.020. Epub 2017 Sep 29. Review. Erratum in: Redox Biol. 2018 Mar 13;:.

20.

Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases.

Zielonka J, Hardy M, Michalski R, Sikora A, Zielonka M, Cheng G, Ouari O, Podsiadły R, Kalyanaraman B.

Cell Biochem Biophys. 2017 Dec;75(3-4):335-349. doi: 10.1007/s12013-017-0813-6. Epub 2017 Jun 29.

21.

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, Cheng G, Lopez M, Kalyanaraman B.

Chem Rev. 2017 Aug 9;117(15):10043-10120. doi: 10.1021/acs.chemrev.7b00042. Epub 2017 Jun 27. Review.

22.

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2017 Oct;13:94-162. doi: 10.1016/j.redox.2017.05.007. Epub 2017 May 18. Review. Erratum in: Redox Biol. 2018 Apr;14 :694-696.

23.

Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.

Kalyanaraman B, Cheng G, Hardy M, Ouari O, Sikora A, Zielonka J, Dwinell MB.

Cell Biochem Biophys. 2017 Dec;75(3-4):311-317. doi: 10.1007/s12013-017-0796-3. Epub 2017 Apr 21.

24.

Green fluorescent proteins induce oxidative stress in cells: A worrisome new wrinkle in the application of the GFP reporter system to biological systems?

Kalyanaraman B, Zielonka J.

Redox Biol. 2017 Aug;12:755-757. doi: 10.1016/j.redox.2017.03.019. Epub 2017 Mar 24. No abstract available.

25.

Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms.

Kalyanaraman B, Cheng G, Hardy M, Ouari O, Sikora A, Zielonka J, Dwinell M.

Interface Focus. 2017 Apr 6;7(2):20160109. doi: 10.1098/rsfs.2016.0109. Review.

26.

Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.

Langley M, Ghosh A, Charli A, Sarkar S, Ay M, Luo J, Zielonka J, Brenza T, Bennett B, Jin H, Ghaisas S, Schlichtmann B, Kim D, Anantharam V, Kanthasamy A, Narasimhan B, Kalyanaraman B, Kanthasamy AG.

Antioxid Redox Signal. 2017 Nov 10;27(14):1048-1066. doi: 10.1089/ars.2016.6905. Epub 2017 Apr 4.

27.

Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.

Zhang Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, Schmidt S, Zielonka J, Perković M, Heckel JO, Cichutek K, Häussinger D, Smits SHJ, Münk C.

J Virol. 2016 Oct 28;90(22):10193-10208. doi: 10.1128/JVI.01497-16. Print 2016 Nov 15.

28.
29.

On the use of peroxy-caged luciferin (PCL-1) probe for bioluminescent detection of inflammatory oxidants in vitro and in vivo - Identification of reaction intermediates and oxidant-specific minor products.

Zielonka J, Podsiadły R, Zielonka M, Hardy M, Kalyanaraman B.

Free Radic Biol Med. 2016 Oct;99:32-42. doi: 10.1016/j.freeradbiomed.2016.07.023. Epub 2016 Jul 22.

30.

Recent developments in detection of superoxide radical anion and hydrogen peroxide: Opportunities, challenges, and implications in redox signaling.

Kalyanaraman B, Hardy M, Podsiadly R, Cheng G, Zielonka J.

Arch Biochem Biophys. 2017 Mar 1;617:38-47. doi: 10.1016/j.abb.2016.08.021. Epub 2016 Aug 30. Review.

31.

Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.

Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, Barrios CS, Weber JJ, Johnson BD, Hardy M, Dwinell MB, Kalyanaraman B.

Cancer Res. 2016 Jul 1;76(13):3904-15. doi: 10.1158/0008-5472.CAN-15-2534. Epub 2016 May 23.

32.

In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor Killing.

Lehmann S, Perera R, Grimm HP, Sam J, Colombetti S, Fauti T, Fahrni L, Schaller T, Freimoser-Grundschober A, Zielonka J, Stoma S, Rudin M, Klein C, Umana P, Gerdes C, Bacac M.

Clin Cancer Res. 2016 Sep 1;22(17):4417-27. doi: 10.1158/1078-0432.CCR-15-2622. Epub 2016 Apr 26.

33.

Mechanism of oxidative conversion of Amplex® Red to resorufin: Pulse radiolysis and enzymatic studies.

Dębski D, Smulik R, Zielonka J, Michałowski B, Jakubowska M, Dębowska K, Adamus J, Marcinek A, Kalyanaraman B, Sikora A.

Free Radic Biol Med. 2016 Jun;95:323-32. doi: 10.1016/j.freeradbiomed.2016.03.027. Epub 2016 Mar 26.

34.

Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation.

Zielonka J, Zielonka M, VerPlank L, Cheng G, Hardy M, Ouari O, Ayhan MM, Podsiadły R, Sikora A, Lambeth JD, Kalyanaraman B.

J Biol Chem. 2016 Mar 25;291(13):7029-44. doi: 10.1074/jbc.M115.702787. Epub 2016 Feb 2.

35.

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus.

Ilag LL, Deeg MA, Costigan T, Hollander P, Blevins TC, Edelman SV, Konrad RJ, Ortmann RA, Pollom RK, Huster WJ, Zielonka JS, Prince MJ.

Diabetes Obes Metab. 2016 Feb;18(2):159-68. doi: 10.1111/dom.12584. Epub 2016 Jan 8.

36.

BIOSIMILARS AND NEW INSULIN VERSIONS.

Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman SV.

Endocr Pract. 2015 Dec;21(12):1387-94. doi: 10.4158/EP14595.RA. Epub 2015 Sep 4. Review.

PMID:
26340139
37.

Toward selective detection of reactive oxygen and nitrogen species with the use of fluorogenic probes--Limitations, progress, and perspectives.

Debowska K, Debski D, Hardy M, Jakubowska M, Kalyanaraman B, Marcinek A, Michalski R, Michalowski B, Ouari O, Sikora A, Smulik R, Zielonka J.

Pharmacol Rep. 2015 Aug;67(4):756-64. doi: 10.1016/j.pharep.2015.03.016. Epub 2015 Apr 11. Review.

38.

Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.

Cheng G, Zielonka J, McAllister D, Hardy M, Ouari O, Joseph J, Dwinell MB, Kalyanaraman B.

Cancer Lett. 2015 Aug 28;365(1):96-106. doi: 10.1016/j.canlet.2015.05.016. Epub 2015 May 21.

39.

Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study.

Blevins TC, Dahl D, Rosenstock J, Ilag LL, Huster WJ, Zielonka JS, Pollom RK, Prince MJ.

Diabetes Obes Metab. 2015 Aug;17(8):726-33. doi: 10.1111/dom.12496. Epub 2015 Jun 23.

PMID:
25974640
40.

Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study).

Rosenstock J, Hollander P, Bhargava A, Ilag LL, Pollom RK, Zielonka JS, Huster WJ, Prince MJ.

Diabetes Obes Metab. 2015 Aug;17(8):734-41. doi: 10.1111/dom.12482. Epub 2015 May 31.

PMID:
25931141
41.

Detection and differentiation between peroxynitrite and hydroperoxides using mitochondria-targeted arylboronic acid.

Zielonka J, Sikora A, Adamus J, Kalyanaraman B.

Methods Mol Biol. 2015;1264:171-81. doi: 10.1007/978-1-4939-2257-4_16.

42.

Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications.

Smulik R, Dębski D, Zielonka J, Michałowski B, Adamus J, Marcinek A, Kalyanaraman B, Sikora A.

J Biol Chem. 2014 Dec 19;289(51):35570-81. doi: 10.1074/jbc.M114.597740. Epub 2014 Nov 5.

43.

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL, Stucky CL, Kanthasamy AG, Kalyanaraman B.

Neurosci Lett. 2014 Nov 7;583:159-64. doi: 10.1016/j.neulet.2014.09.042. Epub 2014 Sep 26.

44.

Real-time measurements of amino acid and protein hydroperoxides using coumarin boronic acid.

Michalski R, Zielonka J, Gapys E, Marcinek A, Joseph J, Kalyanaraman B.

J Biol Chem. 2014 Aug 8;289(32):22536-53. doi: 10.1074/jbc.M114.553727. Epub 2014 Jun 13.

45.

H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology.

Shah G, Zielonka J, Chen F, Zhang G, Cao Y, Kalyanaraman B, See W.

J Urol. 2014 Oct;192(4):1238-48. doi: 10.1016/j.juro.2014.05.115. Epub 2014 Jun 10.

46.

Mitochondria-targeted spin traps: synthesis, superoxide spin trapping, and mitochondrial uptake.

Hardy M, Poulhés F, Rizzato E, Rockenbauer A, Banaszak K, Karoui H, Lopez M, Zielonka J, Vasquez-Vivar J, Sethumadhavan S, Kalyanaraman B, Tordo P, Ouari O.

Chem Res Toxicol. 2014 Jul 21;27(7):1155-65. doi: 10.1021/tx500032e. Epub 2014 Jun 13.

47.

Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.

Cheng G, Zielonka J, McAllister D, Tsai S, Dwinell MB, Kalyanaraman B.

Br J Cancer. 2014 Jul 8;111(1):85-93. doi: 10.1038/bjc.2014.272. Epub 2014 May 27.

48.

Cryoballoon ablation of paroxysmal atrial fibrillation and underlying atrial tachycardia and ectopy arising from a common trigger focus limited to a right inferior pulmonary vein.

Kiedrowicz R, Kaźmierczak J, Wielusiński M, Zielonka J.

Kardiol Pol. 2014;72(5):465. doi: 10.5603/KP.2014.0094. No abstract available.

49.

High-throughput assays for superoxide and hydrogen peroxide: design of a screening workflow to identify inhibitors of NADPH oxidases.

Zielonka J, Cheng G, Zielonka M, Ganesh T, Sun A, Joseph J, Michalski R, O'Brien WJ, Lambeth JD, Kalyanaraman B.

J Biol Chem. 2014 Jun 6;289(23):16176-89. doi: 10.1074/jbc.M114.548693. Epub 2014 Apr 24.

50.

Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells.

Kumar A, Chen SH, Kadiiska MB, Hong JS, Zielonka J, Kalyanaraman B, Mason RP.

Free Radic Biol Med. 2014 Aug;73:51-9. doi: 10.1016/j.freeradbiomed.2014.04.014. Epub 2014 Apr 16.

Supplemental Content

Loading ...
Support Center